IP Library Granted Patent US 8,697,112
Granted Patent B2
US 8,697,112 · App. 13/543,337 · Granted Apr 15, 2014

Method for treating a surface with a coating comprising a microencapsulated therapeutic agent and device with treated surface

Inventors: Vyacheslav Dudnyk (Mississauga, CA); Valerio DiTizio (Toronto, CA)
Assignee: Covalon Technologies
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,697,112
App. No.
13/543,337
Granted
Apr 15, 2014
Kind
B2
Abstract

A method for treating a surface with a therapeutic agent is disclosed. The method comprises precipitating a therapeutic agent from a hydrophilic polymeric base layer with which the therapeutic agent has been complexed, to form a layer comprising microparticles of the therapeutic agent on the hydrophilic polymeric base layer, the hydrophilic polymeric base layer being grafted to the surface. Devices comprising a surface having a hydrophilic polymeric base layer comprising a hydrophilic polymer grafted to the surface and a layer comprising microparticles of a therapeutic agent disposed on and complexed with the hydrophilic polymeric base layer are also disclosed.

Claims (14)

1. A device comprising:

a surface;

a hydrophilic polymeric base layer comprising a hydrophilic polymer grafted to the surface; and

a layer comprising microparticles of a therapeutic agent disposed on and complexed with the hydrophilic polymeric base layer.

2. The device of claim 1 , wherein the device is a medical device.

3. The device of claim 2 , wherein the medical device is an implantable medical device.

4. The device of claim 3 , wherein the implantable medical device comprises a dressing, a pin, a clip, a catheter, a stent, an implant, a tubing, a rod, a prosthesis, a screw, a plate, a stent, an endotracheal tube, a heart valve, a dental implant, or a drug delivery device.

5. The device of claim 2 , wherein the medical device is a device for inducing pleurodesis, preventing restenosis, or for treating tumors.

6. The device of claim 1 , wherein the therapeutic agent comprises silver nitrate.

7. The device of claim 1 , wherein of the microparticles of the therapeutic agent have dimensions in the range of from about 1 μm to about 500 μm.

8. The device of claim 1 , wherein the hydrophilic polymeric base layer has a thickness in the range of about 0.1 μm to about 500 μm.

9. The device of claim 1 , wherein the layer comprising microparticles of the therapeutic agent has a thickness in the range of about 10 μm to about 500 μm.

10. The device of claim 1 , further comprising a hydrophobic polymeric top layer on the layer of the therapeutic agent.

11. The device of claim 10 , wherein the hydrophobic polymeric top layer has a thickness in the range of about 1 μm to about 500 μm.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jul 30, 2021
From: HSBC BANK CANADA
To: COVALON TECHNOLOGIES INC.
Reel/Frame 057039/0414 →
SECURITY INTEREST Recorded Aug 13, 2018
From: COVALON TECHNOLOGIES INC.
To: HSBC BANK CANADA
Reel/Frame 046627/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2012
From: DUDNYK, VYACHESLAV; DITIZIO, VALERIO
To: COVALON TECHNOLOGIES
Reel/Frame 029171/0328 →
Continuity (2)
Provisional Application 61505748 · Jul 8, 2011
Related Publication 20130039953A1 · Feb 14, 2013